Quel est le prix pour Lattice Biologics Ltd. (LBLTF)

Le prix pour Lattice Biologics Ltd. (LBLTF) est $0.0001

Quelle est la capitalisation boursière pour Lattice Biologics Ltd. (LBLTF)

La capitalisation boursière pour Lattice Biologics Ltd. (LBLTF) est $16.55K

Lattice Biologics Ltd. (LBLTF) Prix et Capitalisation Boursière

Lattice Biologics Ltd. is a biotechnology firm focused on developing, manufacturing, and commercializing biological products designed for bone regeneration. These solutions are utilized globally across dental, spinal, and general orthopedic indications. The company's innovative offerings include novel amniotic fluid-based therapies such as AmnioBoost and AmnioBlast. In addition, their product line features a broad range of allografts, encompassing traditional, spinal, particulate, soft tissue, dental, membrane and barrier, and demineralized bone matrix varieties. These versatile products serve numerous critical medical applications, from enhancing spinal fusion and aiding breast reconstruction post-mastectomy to promoting bone regeneration in foot and ankle surgeries and fostering skull healing after neurosurgery. They also play a role in improving wound repair for burn victims, facilitating hernia repair, addressing subchondral bone defects in knee and other joint surgeries, and supporting various sports medicine procedures, including anterior and posterior cruciate ligament repairs. The company's headquarters are located in Belgrade, Montana.

Prix pour LBLTF	L’actif B	La capitalisation boursière de B	Résultats
$32,537.68 $16.55K	NVDA	$5.383T	+32,537,681,737.41%
$26,735.52 $16.55K	AAPL	$4.423T	+26,735,516,392.83%
$25,145.78 $16.55K	GOOG	$4.160T	+25,145,780,492.82%
$22,141.56 $16.55K	MSFT	$3.663T	+22,141,558,298.31%
$17,474.94 $16.55K	AMZN	$2.891T	+17,474,939,733.18%

Prix pour LBLTF

L’actif B

La capitalisation boursière de B

Résultats

$32,537.68 $16.55K